ProPhase Labs PRPH
OTC PRPH
$0.01 0.00 (-9.47%)
As of: Oct 23, 2026 · 11:54 AM EDT

ProPhase Labs (PRPH) Current Deferred Revenue (2018 - 2026)

Updated

ProPhase Labs (PRPH) posted Current Deferred Revenue of $1.44 million for Q2 2026, up 1.4% from $1.42 million a year earlier and up 42.0% from the prior quarter.

Analysis

ProPhase Labs (PRPH) Current Deferred Revenue (2018 - 2026) Analysis & Trends

At the end of FY2025, ProPhase Labs' Current Deferred Revenue came in at $1.5 million, down 11.6% from FY2024.

  • Annual Current Deferred Revenue has declined for three consecutive years, though with a five-year compound annual growth rate of 54.8% (FY2020 to FY2025).
  • In prior years, ProPhase Labs' Current Deferred Revenue was $1.7 million in FY2024 (-28.7%), $2.38 million in FY2023 (-4.7%), $2.5 million in FY2022 (+22.9%) and $2.03 million in FY2021.
  • Quarterly Current Deferred Revenue has run from a low of $1.01 million in Q1 2026 to a high of $2.96 million in Q3 2022 over five years.
  • On a year-over-year basis, Current Deferred Revenue increased in 1 of the last eight quarters, with an average decline of 18.6%.
  • The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q3 2021, with growth of 733.5%; the weakest was Q1 2024, with a decline of 42.6%.
  • According to Business Quant data, Current Deferred Revenue for the three prior quarters was $1.01 million (Q1 2026), $1.5 million (Q4 2025) and $1.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 ProPhase Labs 120,537.60 -425,462.40 226,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.44 Mn
Mar 31, 2026 1.01 Mn
Dec 31, 2025 1.50 Mn
Sep 30, 2025 1.37 Mn
Jun 30, 2025 1.42 Mn
Mar 31, 2025 1.60 Mn
Dec 31, 2024 1.70 Mn
Sep 30, 2024 1.65 Mn
Jun 30, 2024 1.82 Mn
Mar 31, 2024 1.63 Mn
Dec 31, 2023 2.38 Mn
Sep 30, 2023 2.45 Mn
Jun 30, 2023 2.25 Mn
Mar 31, 2023 2.84 Mn
Dec 31, 2022 2.50 Mn
Sep 30, 2022 2.96 Mn
Jun 30, 2022 2.43 Mn
Mar 31, 2022 2.25 Mn
Dec 31, 2021 2.03 Mn
Sep 30, 2021 1.52 Mn
API Access

ProPhase Labs Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PRPH&period=max&api_key=YOUR_API_KEY